Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 22890972)

1.

A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.

Newcombe PJ, Reck BH, Sun J, Platek GT, Verzilli C, Kader AK, Kim ST, Hsu FC, Zhang Z, Zheng SL, Mooser VE, Condreay LD, Spraggs CF, Whittaker JC, Rittmaster RS, Xu J.

Genet Epidemiol. 2012 Jan;36(1):71-83. doi: 10.1002/gepi.21600.

2.

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.

Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA.

J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18.

3.

Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.

Zheng J, Liu F, Lin X, Wang X, Ding Q, Jiang H, Chen H, Lu D, Jin G, Hsing AW, Shao Q, Qi J, Ye Y, Wang Z, Gao X, Wang G, Chu LW, Ouyang J, Huang Y, Chen Y, Gao Y, Shi R, Wu Q, Wang M, Zhang Z, Hu Y, Sun J, Zheng SL, Gao X, Xu C, Mo Z, Sun Y, Xu J.

Prostate. 2012 Apr;72(5):577-83. doi: 10.1002/pros.21462. Epub 2011 Jul 27.

4.

Genetic predisposition to early recurrence in clinically localized prostate cancer.

Borque Á, del Amo J, Esteban LM, Ars E, Hernández C, Planas J, Arruza A, Llarena R, Palou J, Herranz F, Raventós CX, Tejedor D, Artieda M, Simon L, Martínez A, Carceller E, Suárez M, Allué M, Sanz G, Morote J.

BJU Int. 2013 Apr;111(4):549-58. doi: 10.1111/j.1464-410X.2012.11333.x. Epub 2012 Jul 3.

PMID:
22759231
5.

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.

Kader AK, Sun J, Reck BH, Newcombe PJ, Kim ST, Hsu FC, D'Agostino RB Jr, Tao S, Zhang Z, Turner AR, Platek GT, Spraggs CF, Whittaker JC, Lane BR, Isaacs WB, Meyers DA, Bleecker ER, Torti FM, Trent JM, McConnell JD, Zheng SL, Condreay LD, Rittmaster RS, Xu J.

Eur Urol. 2012 Dec;62(6):953-61. doi: 10.1016/j.eururo.2012.05.006. Epub 2012 May 12.

6.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

7.

Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.

Gaj P, Maryan N, Hennig EE, Ledwon JK, Paziewska A, Majewska A, Karczmarski J, Nesteruk M, Wolski J, Antoniewicz AA, Przytulski K, Rutkowski A, Teumer A, Homuth G, Starzyńska T, Regula J, Ostrowski J.

PLoS One. 2012;7(4):e35307. doi: 10.1371/journal.pone.0035307. Epub 2012 Apr 19.

8.

A comprehensive genetic approach for improving prediction of skin cancer risk in humans.

Vazquez AI, de los Campos G, Klimentidis YC, Rosa GJ, Gianola D, Yi N, Allison DB.

Genetics. 2012 Dec;192(4):1493-502. doi: 10.1534/genetics.112.141705. Epub 2012 Oct 10.

9.

Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.

Hsu FC, Sun J, Zhu Y, Kim ST, Jin T, Zhang Z, Wiklund F, Kader AK, Zheng SL, Isaacs W, Grönberg H, Xu J.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1083-8. doi: 10.1158/1055-9965.EPI-09-1176. Epub 2010 Mar 23.

10.

Strategies for developing prediction models from genome-wide association studies.

Wu J, Pfeiffer RM, Gail MH.

Genet Epidemiol. 2013 Dec;37(8):768-77. doi: 10.1002/gepi.21762. Epub 2013 Oct 25.

PMID:
24166696
11.

[Meta-analysis of the Italian studies on short-term effects of air pollution].

Biggeri A, Bellini P, Terracini B; Italian MISA Group.

Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71. Italian.

PMID:
11515188
12.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

13.

Genome-wide two-locus epistasis scans in prostate cancer using two European populations.

Tao S, Feng J, Webster T, Jin G, Hsu FC, Chen SH, Kim ST, Wang Z, Zhang Z, Zheng SL, Isaacs WB, Xu J, Sun J.

Hum Genet. 2012 Jul;131(7):1225-34. doi: 10.1007/s00439-012-1148-4. Epub 2012 Feb 26.

14.

Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.

Regnier-Coudert O, McCall J, Lothian R, Lam T, McClinton S, N'dow J.

Artif Intell Med. 2012 May;55(1):25-35. doi: 10.1016/j.artmed.2011.11.003. Epub 2011 Dec 27.

PMID:
22206941
15.

Known susceptibility SNPs for sporadic prostate cancer show a similar association with "hereditary" prostate cancer.

Cremers RG, Galesloot TE, Aben KK, van Oort IM, Vasen HF, Vermeulen SH, Kiemeney LA.

Prostate. 2015 Apr 1;75(5):474-83. doi: 10.1002/pros.22933. Epub 2015 Jan 5.

PMID:
25560306
16.

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.

Ren S, Xu J, Zhou T, Jiang H, Chen H, Liu F, Na R, Zhang L, Wu Y, Sun J, Yang B, Gao X, Zheng SL, Xu C, Ding Q, Sun Y.

Prostate. 2013 Dec;73(16):1824-35. doi: 10.1002/pros.22721. Epub 2013 Aug 26.

17.

Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.

Ribeiro RJ, Monteiro CP, Azevedo AS, Cunha VF, Ramanakumar AV, Fraga AM, Pina FM, Lopes CM, Medeiros RM, Franco EL.

PLoS One. 2012;7(6):e39236. doi: 10.1371/journal.pone.0039236. Epub 2012 Jun 29.

18.

Logistic random effects regression models: a comparison of statistical packages for binary and ordinal outcomes.

Li B, Lingsma HF, Steyerberg EW, Lesaffre E.

BMC Med Res Methodol. 2011 May 23;11:77. doi: 10.1186/1471-2288-11-77.

19.

Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg CD, Prorok PC.

J Natl Cancer Inst. 2011 Jul 6;103(13):1058-68. doi: 10.1093/jnci/djr173. Epub 2011 May 23.

20.

Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers.

Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE.

PLoS Genet. 2009 Feb;5(2):e1000337. doi: 10.1371/journal.pgen.1000337. Epub 2009 Feb 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk